P53 and cellular glucose uptake

Endocrine Research

Volumn 38, Issue 1, 2013, Pages 32-39

  De La Torre, Alejandro J ^a,b   Rogoff, Daniela ^a   White, Perrin C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Adipocytes; Glucose uptake; Hepatocytes; Insulin; SiRNA; TP53

Indexed keywords

GLUCOSE; INSULIN; PROTEIN P53; PYRUVIC ACID; SMALL INTERFERING RNA; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; MESSENGER RNA; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE; 3T3 CELL LINE; ANIMAL TISSUE; CELL LYSATE; FEMALE; IN VIVO STUDY; PRIMARY CULTURE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 2; HEPATOCYTES; MICE; MICE, KNOCKOUT; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871791673     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2012.710883     Document Type: Article

References (14)

1. Zhang XD, Qin ZH, Wang J. The role of p53 in cell metabolism. Acta Pharmacol Sin 2010;31 (9):1208-1212.
2. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004;64(7):2627-2633.
3. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006;126(1):107-120.
4. Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 2010;20(7):427-434.
5. Canto C, Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 2010;67(20):3407-3423.
6. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007;92(9):3705-3711.
7. Gaulton KJ, Willer CJ, Li Y, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008;57(11):3136-3144.
8. Armata HL, Golebiowski D, Jung DY, Ko HJ, Kim JK, Sluss HK. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol 2010;30(24):5787-5794.
9. Jalving M, Gietema JA, Lefrandt JD, et al. Metformin: taking away the candy for cancer? Eur J Cancer 2010;46(13):2369-2380.
10. Rogoff D, Ryder JW, Black K, et al. Abnormalities of glucose homeostasis and the hypothalamicpituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 2007;148 (10):5072-5080.
11. Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009;15(9):1082-1087.
12. Inoue N, Yahagi N, Yamamoto T, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem 2008;283(30):21220-21229.
13. Nakatsuka A, Wada J, Hida K, et al. RXR antagonism induces G(0)/G(1) cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes. J Pathol 2012;226(5):784-795.
14. Kawagishi H, Wakoh T, Uno H, et al. Hzf regulates adipogenesis through translational control of C/EBPalpha. EMBO J 2008;27(10):1481-1490.